ViriMASK

Company Overview

Snapshot

Founded in March 2020 by Prof. Noam Gavriely, ViriMASK operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing advanced protective masks. In July 2020, ViriMASK introduced an Israeli-made mask claiming superior protection against coronavirus.

Business overview

ViriMASK develops advanced face masks designed to offer comprehensive protection against micron-sized particles, including bacteria and viruses. Its core technology features filters capable of retaining particles larger than 0.1 microns and a full-face design that seals against outside air penetration, covering both eyes and the respiratory system. The masks are engineered for comfortable, extended wear with low airflow resistance and can be washed and disinfected. ViriMASK serves both B2B and B2C markets within the Health Tech & Life Sciences sector, specifically targeting medical technologies and equipment for respiratory protection in hospitals and for individual users.

Strategic signal

In July 2020, ViriMASK garnered attention for its Israeli-made mask, which claimed to offer enhanced protection against coronavirus. This development signaled the company's rapid response to global health crises and its potential to introduce innovative protective equipment to the market, indicating a strong product-market fit in the health tech sector during a period of high demand for such solutions.

Company Intelligence Q&A

When was ViriMASK founded?

ViriMASK was founded in March 2020.

Who founded ViriMASK?

ViriMASK was founded by Prof. Noam Gavriely.

What is ViriMASK's primary product?

ViriMASK's primary product is a full-face oculo-respirator designed to provide maximum protection against micron-sized particles, including bacteria and viruses, by covering the eyes, nose, and mouth with a sealed filtering mechanism.

What was a key product development for ViriMASK in 2020?

In July 2020, ViriMASK introduced an Israeli-made mask that claimed to offer superior protection against coronavirus, highlighting its advanced filtration capabilities.

What markets does ViriMASK target?

ViriMASK targets both B2C and B2B markets, providing protective equipment for individuals and healthcare providers in the medical technologies sector.